Ronald Sills is a lead analyst at Nerac. Nerac provides research, analysis and advice for companies developing innovative medical products.
Unnatural progression Renowned entrepreneur Luke Johnson argues that while a CFO may be the...
The view from the top Richard Solomons became the latest addition to a growing list of...
LowCVP: Fleet vehicles that don’t cost the earth The day is fast approaching when fleet managers will be able to give...
Syngenta: A sustainable growth strategy – we talk to John Ramsay Reorganising the structure of a multinational organisation is a...
Morgan Crucible: Aligning governance, risk and compliance The recent ‘Roads to Ruin’ report by UK association Airmic suggested...
